GLP-1 Drugs & Brain Health: Potential for Neurodegenerative Disease?
Emerging research indicates that glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are commonly prescribed for conditions like type 2 diabetes and obesity, may have potential implications for neurodegenerative diseases (NDDs). A recent review in the Journal of Clinical Investigation explores the biological mechanisms, translational evidence, and clinical potential of these drugs as possible disease-modifying therapies for … Read more